Biochemical and clinical effects of amiflamine-determined by the debrisoquine hydroxylation phenotype?
Year: 1987
Type: article
Study design: Clinical Trial
Source: Nordic Journal of Psychiatry
Institutions: Danderyds sjukhus, Karolinska Institutet, AstraZeneca (Sweden)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2211838714
